Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
Marijuana Industry
Weed is the new craft beer, says former Budweiser exec: 'Ignore it at your peril' - From Financial Post
Chris Burggraeve is one of many entrepreneurs and investors increasingly flocking to the cannabis industry from the traditional business world
Meteoric Rise of Bitcoin, Open Embracing of Blockchain by Sector Majors
The price of bitcoin recently hit an all-time high of more than $7,800, edging closer to Goldman Sachs’ (NYSE: GS) forecast that the cryptocurrency will hit $8,000.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Enters the Multibillion-Dollar Tea Market
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market.
PotNetwork Holding Inc. (POTN) Positioned for a Bright Future in the CBD Market
PotNetwork Holding, Inc. (OTC: POTN) is in a strong position to take advantage of this market growth through its subsidiary, Diamond CBD.
Canadian Licensed Producers Prepare for Recreational Cannabis Legalization, Expect Significant Growth in Demand
A momentous cultural and economic change is soon coming to Canada, as the Canadian Government has committed to legalizing recreational marijuana on July 1, 2018.
Skinvisible, Inc.’s (SKVI) Patented Polymer Delivery Technology Could Take CBD Products to the Next Level
Invisicare®, a proprietary topical drug delivery technology developed by Skinvisible, Inc. has a potentially wide range of applications in the cannabis market.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Unlocks Ability to Produce 90+ Cannabinoids through Biosynthesis
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool.
Leaders in Medical Marijuana and the Global Alzheimer’s Markets
Investors interested in medicinal marijuana and/or Alzheimer’s treatments will find themselves looking at a global landscape of key players.
Skinvisible, Inc.’s (SKVI) Topical Drug Delivery System Set to Enjoy New Licensing Opportunities
Skinvisible, Inc. (OTCQB: SKVI) is set for a business renaissance in the coming years.
Strategic Acquisition Enables Grey Cloak Tech, Inc.’s (GRCK) Development in Two Industries
On October 24, 2017, Grey Cloak Tech, Inc. announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products.
AppSwarm, Inc. (SWRM) Leverages Technology and Business Expertise to Enter the Cannabis Market Through SinglePoint, Inc. (SING) Joint Venture
AppSwarm, Inc. (OTC: SWRM) has four key revenue streams and is using its business and technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING).
Innovative Biotechnology Companies are Transforming Cannabis-based Medical Products
These forward-thinking companies are developing proprietary systems and delivery methods to drive their research and development programs for a leading position in industry breakthroughs.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Seeks to Become A ‘Global Presence’
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) director Aaron Keay said in an interview with CannabisFN (CFN Media) that besides achieving greater market share in Canada, ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Boosts Revenue by Out-Licensing Patented Technology to Third-Party Partners
Lexaria generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners.